Drug intelligence / Profile preview

sodium lactate + sodium chloride + magnesium chloride + calcium chloride + dextrose

Development stage
Approved
Lead developer
Takeda
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

**Sodium lactate + sodium chloride + magnesium chloride + calcium chloride + dextrose** is a multi-electrolyte peritoneal dialysis solution marketed as **Delflex** and developed by Baxter Healthcare for intraperitoneal use in patients with chronic kidney failure maintained on peritoneal dialysis. The combination contains dextrose as the principal osmotic agent to promote ultrafiltration across the peritoneal membrane, while sodium, calcium, magnesium, chloride, and lactate help maintain electrolyte and acid-base balance during dialysis. It is a small-molecule combination product used as a dialysis solution rather than a receptor-targeted pharmacologic agent, and has been marketed in multiple formulations including low magnesium and low calcium variants.

Brand names
Delflex
Other names
sodium lactate + sodium chloride + magnesium chloride + calcium chloride + dextrosedelflex peritoneal dialysis solutionperitoneal dialysis solution

Beyond the preview

Go deeper on sodium lactate + sodium chloride + magnesium chloride + calcium chloride + dextrose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium lactate + sodium chloride + magnesium chloride + calcium chloride + dextrose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call